Annexon

Also known as: Annexon Biosciences | Annexon Chief Medical Officer | Annexon Director, Global Clinical Operations | Annexon, Inc. | Annexon Medical Monitor

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Dec 1, 2016

Last known activity

Jun 30, 2025

Timeline

2010s

Jan 1, 2011
Annexon— Founded

Drugs by trial phase (6 distinct, 15 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

immune globulin (human)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (28)

NCT07020819Lead sponsorPhase 3Jun 30, 2025
NCT07020819OfficialPhase 3Jun 30, 2025
NCT06510816Lead sponsorPhase 3Jul 30, 2024
NCT06510816OfficialPhase 3Jul 30, 2024
NCT05780515Lead sponsorPhase 1Aug 9, 2022
NCT05780515Study directorPhase 1Aug 9, 2022
NCT05521269Study directorPhase 1Jun 27, 2022
NCT05521269Lead sponsorPhase 1Jun 27, 2022
NCT05288881Lead sponsorPhase 1Feb 28, 2022
NCT05288881Study directorPhase 1Feb 28, 2022
NCT04656561Study directorPhase 2Mar 31, 2021
NCT04656561Lead sponsorPhase 2Mar 31, 2021
NCT04691570Lead sponsorPhase 2Jan 31, 2021
NCT04701164Lead sponsorPhase 2/Phase 3Dec 17, 2020
NCT04701164Study directorPhase 2/Phase 3Dec 17, 2020

Details

Founded: San Francisco, CA, US Jan 1, 2011
Last known activity: Jun 30, 2025